Overview
NFQ Level 9, Major Award
The MEngSc in Pharmaceutical and Biopharmaceutical Engineering is a full-time programme running for 12 months from the date of first registration for the programme or a part-time programme programme running for a minimum of 24 months (maximum 60 months) from the date of first registration for the programme.
In Part I students take modules to the value of 60 credits.
Part II consists of a Dissertation to the value of 30 credits. The choice of modules is subject to the approval of the Programme Director.
Individual Modules
Candidates who satisfy the programme eligibility criteria may, subject to the approval of the Programme Coordinator, be permitted to take individual modules, as part of UCC's commitment to Continuing Professional Development (CPD), and be provided with a relevant transcript of marks.
Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering
Students who pass all modules in Part I but fail to achieve the requisite grade of 50% across the taught modules will be eligible for the award of a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering. A candidate who passes Part I of the programme and who does not wish to proceed to Part II, may opt to be conferred with a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering.
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
Module List | Code | Title | Credits |
| |
| 60 |
| Biopharmaceutical Supporting Systems (5) | |
| Pharmaceutical Engineering (5) | |
| Biopharmaceutical Engineering (5) | |
| Pharmaceutical Process Equipment, Materials and Mechanical Design (5) | |
| Powder and Particle Technology and Unit Operations (5) | |
| Process Analytical Technology (5) | |
| Advanced Biopharmaceutical Engineering (5) | |
| Introductory Pharmaceutical Chemistry (5) | |
| Process Optimisation in the Pharmaceutical Industry (5) | |
| Pharmaceutical Process Validation and Quality (5) | |
| Aseptic Manufacturing Design (5) | |
| Process Design and Safety Engineering (5) | |
| Project Engineering - From Concept to Completion (5) | |
| |
| PE6021 | Dissertation in Pharmaceutical and Biopharmaceutical Engineering | 30 |
| Total Credits | 90 |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for MEngSc in Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
- Apply an enhanced knowledge and understanding of the mathematics, sciences, engineering sciences and technologies to pharmaceutical and biopharmaceutical engineering;
- Plan, research, execute and oversee a substantial research project, critically analyse and interpret data, and effectively disseminate the results;
- Identify, formulate, analyse and solve problems related to pharmaceutical and biopharmaceutical engineering;
- Design pharmaceutical and biopharmaceutical manufacturing facilities and processes, including unfamiliar, ill-defined scenarios, underpinned by a sustainability informed paradigm, taking account of environmental, health and safety and risk factors, and know how to apply relevant codes of practice, industry standards and emerging practices and technologies;
- Gather experimental data, apply a range of standard and specialized research tools and techniques and conduct critical evaluation of results;
- Reflect and act on social and ethical responsibilities in the practice of engineering, including the responsibilities towards developing sustainable processes and operations;
- Work effectively as an individual and in teams in planning and carrying through on assignments and projects in a lifelong learning context;
- Communicate effectively with the engineering community and with society at large.
